Relevant bibliographies by topics / Heart failure

Academic literature on the topic 'Heart failure'

Author: Grafiati
Published: 4 June 2021
Last updated: 6 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Heart failure.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Heart failure"

1

Struthers, A. D. "HEART FAILURE: The diagnosis of heart failure." Heart 84, no. 3 (September 1, 2000): 334–38. http://dx.doi.org/10.1136/heart.84.3.334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Westaby, S. "HEART FAILURE: Non-transplant surgery for heart failure." Heart 83, no. 5 (May 1, 2000): 603. http://dx.doi.org/10.1136/heart.83.5.603.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Pingitore, Alessandro, Francesca Mastorci, and Giorgio Iervasi. "Heart Failure and Stress Response." Biomed Data Journal 1, no. 3 (2015): 33–35. http://dx.doi.org/10.11610/bmdj.01300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

McMurray, J. J. "HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failure." Heart 83, no. 5 (May 1, 2000): 596–602. http://dx.doi.org/10.1136/heart.83.5.596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Coats, A. J. S. "HEART FAILURE: What causes the symptoms of heart failure?" Heart 86, no. 5 (November 1, 2001): 574–78. http://dx.doi.org/10.1136/heart.86.5.574.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Eyubova, UA. "Modern Treatment Methods of Heart Failure." Clinical Cardiology and Cardiovascular Interventions 3, no. 9 (October 16, 2020): 01–02. http://dx.doi.org/10.31579/2641-0419/082.

Full text
Abstract:
Modern methods of treatment of heart include, first of all, pathogenetic therapy and modern methods of treatment. Complete pathogenetic treatment has been achieved after the use of sacubitril / valsartan which is neprilysin inhibitor, whose use has been initiated in recent years. According to data provided in 2017, 26 million people worldwide suffer from heart failure.
APA, Harvard, Vancouver, ISO, and other styles
7

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (October 15, 2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.178-187.

Full text
Abstract:
Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequency distribution. Respondents involved in the study were patients aged >18 years who suffered from CHF based on a doctor's diagnosis and confirmed by medical records. Results: The majority of respondents are elderly with female gender, work as household workers, and heve income less than Rp1,500,000/month. Examination of vital signs performed on the majority of CHF patients showed normal temperature (36.5℃ - 37.5℃), pre-hypertensive blood pressure (120/80 - 139/89 mmHg), normal pulse (60-100x/min), and normal respiratory rate (12-20x/minute). Most patients have a CHF duration of 1–3 years, and are in grades 2 and 3 based on the New York Association (NYHA) classification. The results of this study were 65.9% of CHF patients experienced moderate fatigue, 17.6% severe fatigue, and 16.5% mild fatigue. Conclusion: Health services can consider efforts to improve the quality of nursing services in overcoming or minimizing fatigue experienced by CHF patients. These efforts can be a therapy, evidence-based health education, or fatigue monitoring for preventing a worsening of disease prognosis and improving the patient's quality of life. Keywords: CHF, Fatigue, Multidimensional Assesment Fatigue.
APA, Harvard, Vancouver, ISO, and other styles
8

Setianingsih, Mauludina Putri, and Yuni Dwi Hastuti. "Kelelahan pada Pasien Congestive Heart Failure." Holistic Nursing and Health Science 5, no. 2 (October 15, 2022): 178–87. http://dx.doi.org/10.14710/hnhs.5.2.2022.34-43.

Full text
Abstract:
Introduction: Fatigue is a characteristic symptom and is often found in CHF patients and has a negative effect on daily activities, disease prognosis, and patient's quality of life. However, fatigue is a common symptom that is often overlooked and ignored. Limited study explored fatigue in CHF patients. The aim of this study was to explore fatigue in CHF patients. Methods: The research design is a descriptive survey. The total research sample is 85 respondents. Data were taken using a Multidimensional Assessment Fatigue (MAF) questionnaire with univariate data analysis in the form of a frequency distribution. Respondents involved in the study were patients aged >18 years who suffered from CHF based on a doctor's diagnosis and confirmed by medical records. Results: The majority of respondents are elderly with female gender, work as household workers, and heve income less than Rp1,500,000/month. Examination of vital signs performed on the majority of CHF patients showed normal temperature (36.5℃ - 37.5℃), pre-hypertensive blood pressure (120/80 - 139/89 mmHg), normal pulse (60-100x/min), and normal respiratory rate (12-20x/minute). Most patients have a CHF duration of 1–3 years, and are in grades 2 and 3 based on the New York Association (NYHA) classification. The results of this study were 65.9% of CHF patients experienced moderate fatigue, 17.6% severe fatigue, and 16.5% mild fatigue. Conclusion: Health services can consider efforts to improve the quality of nursing services in overcoming or minimizing fatigue experienced by CHF patients. These efforts can be a therapy, evidence-based health education, or fatigue monitoring for preventing a worsening of disease prognosis and improving the patient's quality of life. Keywords: CHF, Fatigue, Multidimensional Assesment Fatigue.
APA, Harvard, Vancouver, ISO, and other styles
9

Kishanrao, Suresh. "Congestive Heart Failure in Indian Elders." Clinical Cardiovascular Research 2, no. 1 (March 1, 2023): 01–04. http://dx.doi.org/10.58489/2836-5917/006.

Full text
Abstract:
Congestive Heart Failure (CHF) is a common complex clinical syndrome that underlines the inability of the heart to perform its circulatory function with the desired efficiency due to structural and/or functional alterations. There is paucity of good and reliable data in India and many developing countries on heart failure. The management of heart failurehas evolved over the years with the advent of new drugs and devices.But there is a need to uneartha true and meaningful nationaldata on the risk factors,available treatment options,and challenges in management that could be addressed to take advantage of the recent advances. CHF is a disease of the “elderly,” frequently occurs in the setting of normal ejection fraction, and has a poor prognosis, regardless of the level of systolic function. The highest prevalence of CHF is reported among Indigenous Australian population (5.3%), Germany (4%) and Canada 3.6%, Turkey 2.9%, and USA 2.6% as compared to only 0.3% in Indian population. Overall, more than 5 persons aged 60 to 69 and 10 persons per 1,000 population after 65 years of age suffer from CHF. The incidence of CHF is equally frequent in men and women globally, but it is more amongelderly women in India comparedto elderly men. The burden of heart failure is increasing at an alarming rate worldwide as well as in India. CHF not only increases the risk of mortality, morbidity and worsens the patient’s quality of life, but also puts a huge burden on the overall healthcare system. We need to acknowledge the fact that diagnostic and therapeutic methods available are also underused in the community. This review article is the result of witnessing the heart failure in 4 individuals in January 2023. Their symptomsand signs included Shortness of breath with routine activity like walking or household chores, fatigue, and weakness, Pedal oedema, rapid or irregular heartbeat, fluctuating Blood Pressure and Blood sugar levels, reduced ability to exercise and vomiting and aspirational pneumonia. The exponential rise in the incidence of uncontrolled hypertension and DM over the last couple of years has shaped the trajectory of HF development seen today. The key risk factors and causes of HF in our cases included hypertension (HT), diabetes mellitus (DM); chronic kidney disease (CKD). With the bestpossible management practices in cities likeBengaluru and Mysuru in Karnataka we could save only two of the 4 cases,both first-time hospitalized patients. Materials & Methods: The third week of January2023 (17-25 January), the author had a misfortune being a witnessfor 3 women and one man between 64-85 years of age’s hospitalized for CHF with an outcome of 50% of them succumbing to CHF. This manuscript is a review of available information on the websites of World Heart Federation 2020, WHO, Global burden of disease 2019 report, ICC - National Heart Failure Registry, Reports of the Best Charities that fight Heart Diseases in 2023 including American Heart Association, The Children’s Heart Foundation, British Heart Foundation, Mended Hearts, Women Heart, Needy heart Foundation Bangalore and published papers in Indiaas evidences.
APA, Harvard, Vancouver, ISO, and other styles
10

Maggioni, A. P. "HEART FAILURE: Treatment strategies for heart failure: beta blockers and antiarrhythmics." Heart 85, no. 1 (January 1, 2001): 97–103. http://dx.doi.org/10.1136/heart.85.1.97.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Heart failure"

1

Williams, Michael Todd. "Heart Failure Readmission Strategy via Heart Failure Script." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4189.

Full text
Abstract:
Hospital administrators strive to reduce readmission and over use of the acute care setting for chronic health conditions. Historically hospitals have focused on readmission prevention strategies to improve the transition of patients from the hospital to the community and although the causes of a hospital readmission may span multiple providers along the continuum of care, the hospital is currently the only provider being penalized. The project facility implemented a readmission reduction strategy, Re-Engineered Discharge (Project RED), as a means to reduce readmissions and yet continued to have high readmission rates for heart failure (HF) patients. The continued high rate of readmissions led to the practice focused question, which examined the process of developing a discharge phone call script specific for HF patients as a way to reduce readmissions for HF patients. Kristin Swanson's structure of caring model provided the nursing framework for this project with a purpose to plan a telephone call follow up program for HF patients after hospital discharge. The project planning was accomplished in conjunction with the facility's readmission reduction team/LEAN team, resulting in a script about the most prevalent issues among HF patients. Kotter's 8 step change model will be used as a guide for the implementation of the telephone call follow up program at a later date. Readmission rates for HF patients will be monitored monthly as an outcome evaluation measure. Project team members provided evaluation of the project which demonstrated satisfaction and success of the planning process. The results of this project will bring about social change by providing access to healthcare providers regardless the socioeconomic status of the patient and by decreasing the use of acute care setting unnecessarily for chronic conditions.
APA, Harvard, Vancouver, ISO, and other styles
2

MacDonald, Michael Ross. "Diabetes and heart failure." Thesis, University of Aberdeen, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.540346.

Full text
Abstract:
The aim of this thesis was to explore the relationship between diabetes and heart failure, particularly focusing on epidemiology, aetiology and treatment. I was granted access to a number of databases that included patients with both diabetes and heart failure. Chapter one is a systematic review of the literature and each subsequent chapter describes an analysis of the individual patient cohorts. Chapters two to five examine the association of diabetes with both short and long-term outcomes in populations with different types of heart failure: out-patients with chronic heart failure; acute heart failure; incident heart failure; and patients at high risk of heart failure following myocardial infarction. In the short-term, diabetes is not associated with increased mortality. It is, however, associated with an increased risk of heart failure. In the long-term, diabetes is associated with an increased risk of death and heart failure. The association of diabetes with prognosis is independent of age and co-morbidity. Chapter six examines the risk of unrecognised myocardial infarction in a diabetic cohort from the RECORD study. Unrecognised myocardial infarction may be an aetiological factor in the development of heart failure in diabetes. Chapter 7 is a case-control study of the GPRD cohort that examines the use of anti-diabetic treatments in patients with heart failure. Of all the treatments metformin was the only treatment associated with improved mortality. Diabetes and heart failure are so common and carry such a poor prognosis, when present together, that even a small advance in their treatment could result in considerable improvement in outcomes.
APA, Harvard, Vancouver, ISO, and other styles
3

Elborn, Joseph Stuart. "Studies in heart failure." Thesis, Queen's University Belfast, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.335936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tan, Yu Ting. "Understanding diastolic heart failure." Thesis, University of Birmingham, 2013. http://etheses.bham.ac.uk//id/eprint/4392/.

Full text
Abstract:
Many patients who present with symptoms of heart failure are found to have a normal left ventricular ejection fraction and therefore were labelled as having “diastolic heart failure” implying that the underlying pathophysiology is due to diastolic dysfunction alone. However, using a combination of echocardiographical techniques, a variety of abnormalities were found including reduced longitudinal function, impaired left ventricular twist and torsional dyssynchrony in systole leading to reduced and delayed untwisting, impaired suction and reduced early diastolic left ventricular filling not fully compensated for in late diastole due to left atrial dysfunction. Furthermore in a group of subjects with treated hypertension, the most common risk factor for this form of heart failure, despite a normal resting echocardiogram, there were already substantial abnormalities of both systolic and diastolic function which were only apparent on exercise. Thus these studies have demonstrated that in heart failure with a normal ejection fraction, there are major abnormalities of systolic function especially torsion or twist, which impact on diastolic filling and that the condition is not due to diastolic dysfunction alone. In addition, these findings emphasise the importance of exercise echocardiography for diagnosis and detecting early left ventricular dysfunction before patients progress to developing heart failure.
APA, Harvard, Vancouver, ISO, and other styles
5

O'Donnell, Johanna. "Predicting heart failure deterioration." Thesis, University of Oxford, 2017. http://ora.ox.ac.uk/objects/uuid:f7e51226-128b-44eb-8f6a-557f1d0c9a53.

Full text
Abstract:
Chronic heart failure (HF) is a condition that affects more than 900,000 people in the UK. Mortality rates associated with the condition are high, with nearly 20% of patients dying within one year of diagnosis. Continuous monitoring and risk stratification can help identify patients at risk of deterioration and may consequently improve patients' likelihood of survival. Current repeated-measure risk stratification techniques for HF patients often rely on subjective perception of symptoms, such as breathlessness, and markers of fluid retention in the body (e.g. weight). Despite the common use of such markers, studies have shown that they offer limited effectiveness in predicting HF-related events. This thesis set out to identify and evaluate new markers for repeated-measure risk stratification of HF patients. It started with an exploration of traditional HF measurements, including weight, blood pressure, heart rate and symptom scores, and aimed to improve the performance of these measurements using a data-driven approach. A multi-variate model was developed from data acquired during a randomised controlled trial of remotely-monitored HF patients. The rare occurrence of HF-related adverse events during the trial required the developement of a careful methodology. This methodology helped identify the markers with most predictive ability, which achieved moderate performance at identifying patients at risk of HF-related adverse events, clearly outperforming commonly-used thresholds. Subsequently, this thesis explored the potential value of additional, accelerometer-derived physical activity (PA) and sleep markers. For this purpose, the ability of accelerometer-derived markers to differentiate between individuals with and without HF was evaluated. It was found that markers that summarise the frequency and duration of different PA intensities performed best at differentiating between the two groups and may therefore be most suitable for future use in repeated-measure applications. As part of the analysis of accelerometer-derived HF markers, a gap in the methodology of automated accelerometer processing was identified, namely the need for self-reported sleep-onset and wake-up information. As a result, Chapter 5 of this thesis describes the development and evaluation of a data-driven solution for this problem. In summary, this thesis explored both traditional and new, accelerometer-derived markers for the early detection of HF deterioration. It utilised sound methodology to overcome limitations faced by sparse and unbalanced datasets and filled a methodological gap in the processing of signals from wrist-worn accelerometers.
APA, Harvard, Vancouver, ISO, and other styles
6

Huiskes, Bonita Louise. "Advanced heart failure in older women with heart failure and preserved systolic function." Diss., Search in ProQuest Dissertations & Theses. UC Only, 2009. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3390049.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Khand, Aleem U. "Arterial fibrillation and heart failure." Thesis, University of Glasgow, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.288911.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gwadry-Sridhar, Femida Guyatt Gordon Henry. "Educating patients with heart failure /." [Hamilton, Ont.] : McMaster University, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wrigley, Benjamin J. "Monocyte subsets in heart failure." Thesis, University of Leicester, 2013. http://hdl.handle.net/2381/28383.

Full text
Abstract:
Introduction: Monocytes play important roles in inflammation, thrombosis, angiogenesis and tissue repair and may contribute to the pathophysiology of heart failure (HF). Functional diversity is likely to stem from the presence of three distinct monocyte subsets, defined by flow cytometry (FC) as CD14++CD16-CCR2+ (Mon1), CD14++CD16+CCR2+ (Mon2) and CD14+CD16++CCR2- (Mon3). The aims of this thesis were to study the following parameters in patients with ischaemic HF: 1) monocyte subset numbers, 2) monocyte subset expression of surface receptors for inflammation, angiogenesis, cell adhesion molecules (CAM) and tissue repair, 3) cross-talk between monocytes and platelets in the formation of monocyte-platelet aggregates (MPAs). Methods: Monocyte subsets were analysed by FC on venous blood samples at baseline in 51 patients admitted with acute HF (AHF), 42 with stable HF (SHF), 44 with stable coronary artery disease (CAD) without HF and 40 healthy controls (HC). Plasma levels of inflammatory cytokines were also measured by flow cytometric bead array technology. In AHF, additional longitudinal samples were taken at discharge and 3 months. Results: Compared to CAD controls, patients with SHF had higher counts of Mon2 and MPAs associated with Mon2, alongside increased expression of inflammatory markers and CAM receptors on Mon2. Compared to SHF, those with AHF had higher counts of Mon1, Mon2 and MPAs associated with Mon1 and Mon2. Patients with AHF also had increased expression of angiogenic receptors on Mon1 and increased expression of angiogenic receptors, scavenger receptors and CAM receptors on Mon2. After adjusting for confounders, counts of Mon2, MPAs associated with Mon2 and expression of VCAM-1R on Mon2 were associated with clinical outcomes in AHF. Conclusions: Differences in monocyte subset numbers and cell surface receptor expression are seen in patients with HF. Mon2 appears to have a prognostic role in patients with AHF, however larger studies are required to confirm these findings.
APA, Harvard, Vancouver, ISO, and other styles
10

Narayan, Hafid. "Guanylin peptides in heart failure." Thesis, University of Leicester, 2013. http://hdl.handle.net/2381/28515.

Full text
Abstract:
This study investigated the role of prouroguanylin (ProUGN) and proguanylin (ProGN), members of a novel class of peptides with natriuretic activity in heart failure (HF), a disorder of declining cardiac output associated with disturbed sodium and water homeostasis. The hypothesis was that ProUGN and ProGN activity is dysregulated in chronic and acute HF. Plasma ProUGN and ProGN were measured in 243 patients with chronic stable HF and plasma ProUGN and cGMP, an intracellular mediator of ProUGN activity, measured in 336 patients admitted to hospital with acute HF using immunoassays. ProUGN and cGMP levels were repeated in acute HF patients prior to discharge. The primary endpoints were all cause mortality, HF readmission and either outcome at 180 days. ProUGN and ProGN were significantly greater in patients with chronic HF compared to controls and inversely correlated with eGFR. ProUGN and ProGN were significantly greater in patients with hypertension and in those taking diuretics, with higher levels associated with increased severity of HF as assessed by NYHA class. In multivariate analysis, eGFR was the only independent predictor of plasma ProUGN and ProGN level. ProUGN and cGMP were significantly lower in patients with acute HF compared to in controls. Pre-discharge ProUGN and cGMP were significantly greater than at admission, with pre-discharge ProUGN significantly greater than in controls. Admission ProUGN was significantly greater in patients who died and a greater pre-discharge ProUGN was significantly associated with increased risk of early mortality. Pre-discharge cGMP levels were significantly lower in those readmitted with HF compared to those not, with higher levels significantly associated with reduced risk of early HF readmission. A greater pre-discharge ProUGN/cGMP ratio was significantly associated with increased risk of mortality or HF readmission. These results suggest that adverse outcomes in HF may be associated with hyporesponsiveness to ProUGN.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Heart failure"

1

David, McCall, and Rahimtoola Shahbudin H, eds. Heart failure. New York, N.Y: Chapman & Hall, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jessup, Mariell L., and Evan Loh. Heart Failure. New Jersey: Humana Press, 2003. http://dx.doi.org/10.1385/159259347x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

FACC, John JV McMurray BSc MD FRCP FESC. Heart Failure. Edited by Andrew L. Clark MA MD MRCP. Abingdon, UK: Taylor & Francis, 1988. http://dx.doi.org/10.4324/9780203213773.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kalogeropoulos, Andreas P., Hal A. Skopicki, and Javed Butler. Heart Failure. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9780429244544.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kitabatake, Akira, Shigetake Sasayama, Gary S. Francis, and Hiroshi Okamoto, eds. Heart Failure. Tokyo: Springer Japan, 2000. http://dx.doi.org/10.1007/978-4-431-68331-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Feldman, David S., and Paul Mohacsi, eds. Heart Failure. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-98184-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Marín-García, José. Heart Failure. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-147-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Eisen, Howard, ed. Heart Failure. London: Springer London, 2017. http://dx.doi.org/10.1007/978-1-4471-4219-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bauersachs, Johann, Javed Butler, and Peter Sandner, eds. Heart Failure. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59659-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Feldman, Arthur M., ed. Heart Failure. Oxford, UK: Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444314427.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Heart failure"

1

Theisler, Charles. "Heart Failure/Congestive Heart Failure." In Adjuvant Medical Care, 156–60. New York: CRC Press, 2022. http://dx.doi.org/10.1201/b22898-170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Friedewald, Vincent E. "Heart Failure (CHF/Congestive Heart Failure)." In Clinical Guide to Cardiovascular Disease, 673–731. London: Springer London, 2016. http://dx.doi.org/10.1007/978-1-4471-7293-2_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

King, Michael R. "Heart Failure." In Family Medicine, 1015–27. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Koshman, Sheri L., and Lesley C. Beique. "Heart Failure." In Patient Assessment in Clinical Pharmacy, 185–99. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rich, Michael W. "Heart Failure." In Cardiovascular Disease and Health in the Older Patient, 172–201. Chichester, UK: John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118451786.ch8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Stewart, Simon. "Heart failure." In The Heart of Africa, 189–91. Chichester, UK: John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119097136.part6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Norcross, William A., and Denise D. Hermann. "Heart Failure." In Family Medicine, 693–703. New York, NY: Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chesler, Elliot. "Heart Failure." In Clinical Cardiology, 166–88. New York, NY: Springer New York, 1993. http://dx.doi.org/10.1007/978-1-4613-9183-8_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Sabol, Valerie. "Heart Failure." In Encyclopedia of Behavioral Medicine, 1046–47. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Orbell, Sheina, Havah Schneider, Sabrina Esbitt, Jeffrey S. Gonzalez, Jeffrey S. Gonzalez, Erica Shreck, Abigail Batchelder, et al. "Heart Failure." In Encyclopedia of Behavioral Medicine, 950–51. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_116.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Heart failure"

1

Böhm, Michael, and Robert van den Heuvel. "EMPEROR-Preserved: Empagliflozin stable across age groups." In Heart Failure 2022, edited by Michael Böhm and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/9521d0a1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Metra, Marco, and Robert van den Heuvel. "Significant improvement in BP from istaroxime, a novel non-adrenergic agent." In Heart Failure 2022, edited by Marco Metra and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/5a83a465.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

García-Pavía, Pablo, and Robert van den Heuvel. "HELIOS-A: Vutrisiran meets exploratory endpoints." In Heart Failure 2022, edited by Pablo García-Pavía and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/8edc2bea.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lena, Alessia, and Robert van den Heuvel. "Cardiac wasting relevant for clinical outcomes in cancer." In Heart Failure 2022, edited by Alessia Lena and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/3d05d88c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Núñez Villota, Julio, and Robert van den Heuvel. "DAPA-VO2: Rapid effect of dapagliflozin on peak VO2 in stable HFrEF." In Heart Failure 2022, edited by Julio Núñez Villota and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/ba2d7a79.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Butt, Jawad, and Robert van den Heuvel. "DAPA-HF: Dapagliflozin is safe and efficacious in frail patients." In Heart Failure 2022, edited by Jawad Butt and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/09fe8c46.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lund, Lars, and Robert van den Heuvel. "Ghrelin improves cardiac output in HFrEF." In Heart Failure 2022, edited by Lars Lund and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/6e8de9aa.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Filippatos, Gerasimos, and Robert van den Heuvel. "FIDELITY: Cardiorenal benefits of finerenone, regardless of LVH status." In Heart Failure 2022, edited by Gerasimos Filippatos and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/5738a863.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Voors, Adriaan, and Robert van den Heuvel. "SERENADE: Macitentan fails in HFpEF plus PAH." In Heart Failure 2022, edited by Adriaan Voors and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/596ea84f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wallner, Markus, and Robert van den Heuvel. "Combination of filgrastim and dutogliptin appears safe in STEMI." In Heart Failure 2022, edited by Markus Wallner and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/7f5d69f7.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Heart failure"

1

liao, xiaoqian, xingyu fan, ziyi wang, shumin huang, and zhixi hu. Prognostic value of heart-type fatty acid binding protein in heart failure: a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0126.

Full text
Abstract:
Review question / Objective: (1)Can heart type fatty acid binding protein effectively predict the prognosis of patients with heart failure? (2)Is high expression of ear type fat acid binding protein associated with poor clinical outcomes in patients with heart failure? Condition being studied: Heart-type fatty acid binding protein (H-FABP) mainly exists in cardiomyocytes and is a potential biomarker of myocardial injury.However, the adverse consequences of heart failure have not been fully analyzed.Therefore, the purpose of this study was to comprehensively evaluate the correlation between H-FABP and the prognosis of heart failure through meta-analysis.
APA, Harvard, Vancouver, ISO, and other styles
2

De Jong, Marla J., Varda Konstam, and Debra K. Moser. Depression, Anxiety and Heart Failure: A Review. Fort Belvoir, VA: Defense Technical Information Center, March 2005. http://dx.doi.org/10.21236/ada430713.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Yujia, and Wen Li. Periodontitis Increase the Risk of Heart Failure. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0084.

Full text
Abstract:
Review question / Objective: Can periodontitis increase the risk of heart failure? Condition being studied: Previous studies reported that periodontal disease is associated with higher risk of HF. However, their conclusions conflicted a little bit with each other. In this case, a systematic review may help drawing a more comprehensive conclusion. Therefore, the purpose of the present analysis is to tell if periodontitis is associated with HF as well as the subtypes of HF.
APA, Harvard, Vancouver, ISO, and other styles
4

Brown, Yolanda, Twonia Goyer, and Maragaret Harvey. Heart Failure 30-Day Readmission Frequency, Rates, and HF Classification. University of Tennessee Health Science Center, December 2020. http://dx.doi.org/10.21007/con.dnp.2020.0002.

Full text
Abstract:
30 Day Hospital Readmission Rates, Frequencies, and Heart Failure Classification for Patients with Heart Failure Background Congestive heart failure (CHF) is the leading cause of mortality, morbidity, and disability worldwide among patients. Both the incidence and the prevalence of heart failure are age dependent and are relatively common in individuals 40 years of age and older. CHF is one of the leading causes of inpatient hospitalization readmission in the United States, with readmission rates remaining above the 20% goal within 30 days. The Center for Medicare and Medicaid Services imposes a 3% reimbursement penalty for excessive readmissions including those who are readmitted within 30 days from prior hospitalization for heart failure. Hospitals risk losing millions of dollars due to poor performance. A reduction in CHF readmission rates not only improves healthcare system expenditures, but also patients’ mortality, morbidity, and quality of life. Purpose The purpose of this DNP project is to determine the 30-day hospital readmission rates, frequencies, and heart failure classification for patients with heart failure. Specific aims include comparing computed annual re-admission rates with national average, determine the number of multiple 30-day re-admissions, provide descriptive data for demographic variables, and correlate age and heart failure classification with the number of multiple re-admissions. Methods A retrospective chart review was used to collect hospital admission and study data. The setting occurred in an urban hospital in Memphis, TN. The study was reviewed by the UTHSC Internal Review Board and deemed exempt. The electronic medical records were queried from July 1, 2019 through December 31, 2019 for heart failure ICD-10 codes beginning with the prefix 150 and a report was generated. Data was cleaned such that each patient admitted had only one heart failure ICD-10 code. The total number of heart failure admissions was computed and compared to national average. Using age ranges 40-80, the number of patients re-admitted withing 30 days was computed and descriptive and inferential statistics were computed using Microsoft Excel and R. Results A total of 3524 patients were admitted for heart failure within the six-month time frame. Of those, 297 were re-admitted within 30 days for heart failure exacerbation (8.39%). An annual estimate was computed (16.86%), well below the national average (21%). Of those re-admitted within 30 days, 50 were re-admitted on multiple occasions sequentially, ranging from 2-8 re-admissions. The median age was 60 and 60% male. Due to the skewed distribution (most re-admitted twice), nonparametric statistics were used for correlation. While graphic display of charts suggested a trend for most multiple re-admissions due to diastolic dysfunction and least number due to systolic heart failure, there was no statistically significant correlation between age and number or multiple re-admissions (Spearman rank, p = 0.6208) or number of multiple re-admissions and heart failure classification (Kruskal Wallis, p =0.2553).
APA, Harvard, Vancouver, ISO, and other styles
5

Iovev, Svetoslav, Peyo Simeonov, and Milena Staneva. Thoracic Impedance Monitoring in Patients with Heart Failure. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, September 2018. http://dx.doi.org/10.7546/crabs.2018.09.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cao, Yang, Pengxiao Li, Qiang Hu, Yi Li, and Yaling Han. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2021. http://dx.doi.org/10.37766/inplasy2021.8.0080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Liang, Zhikun Zhao, Shasha Wang, and Jiajia Wang. Stress hyperglycemia ratio and outcome of heart failure. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2024. http://dx.doi.org/10.37766/inplasy2024.3.0080.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

De Jong, Marla J., and David C. Randall. Heart Rate Variability Analysis in the Assessment of Autonomic Function in Heart Failure. Fort Belvoir, VA: Defense Technical Information Center, July 2004. http://dx.doi.org/10.21236/ada425014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Keith, Felicia. Anger, Hostility, and Re-hospitalizations in Patients with Heart Failure. Fort Belvoir, VA: Defense Technical Information Center, March 2015. http://dx.doi.org/10.21236/ad1012709.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hood, Maureen N. Magnetic Resonance Imaging of Heart Failure Using a Swine Model. Fort Belvoir, VA: Defense Technical Information Center, February 2011. http://dx.doi.org/10.21236/ad1013345.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Heart failure' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography